Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

New oral anticoagulants: good but not good enough!

Kaluski E, Maher J, Gerula CM.

J Am Coll Cardiol. 2012 Oct 9;60(15):1434; author reply 1434-5. doi: 10.1016/j.jacc.2012.06.027. No abstract available.

PMID:
23036632
[PubMed - indexed for MEDLINE]
Free Article
2.

New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper.

De Caterina R, Husted S, Wallentin L, Andreotti F, Arnesen H, Bachmann F, Baigent C, Huber K, Jespersen J, Kristensen SD, Lip GY, Morais J, Rasmussen LH, Siegbahn A, Verheugt FW, Weitz JI; Coordinating Committee.

J Am Coll Cardiol. 2012 Apr 17;59(16):1413-25. doi: 10.1016/j.jacc.2012.02.008. Review.

PMID:
22497820
[PubMed - indexed for MEDLINE]
Free Article
3.

Mouse models, risk factors, and treatments of venous thrombosis.

Mackman N.

Arterioscler Thromb Vasc Biol. 2012 Mar;32(3):554-5. doi: 10.1161/ATVBAHA.112.246173. No abstract available.

PMID:
22345592
[PubMed - indexed for MEDLINE]
Free Article
4.

A new generation of oral direct anticoagulants.

Soff GA.

Arterioscler Thromb Vasc Biol. 2012 Mar;32(3):569-74. doi: 10.1161/ATVBAHA.111.242834. Review.

PMID:
22345595
[PubMed - indexed for MEDLINE]
Free Article
5.

The current role of anticoagulants in cardiovascular medicine.

De Caterina R.

J Cardiovasc Med (Hagerstown). 2009 Aug;10(8):595-604. doi: 10.2459/JCM.0b013e32832e490b. Review.

PMID:
19571765
[PubMed - indexed for MEDLINE]
6.

The need for new oral anticoagulants in clinical practice: an introduction.

Bode C, Verheugt FW.

J Cardiovasc Med (Hagerstown). 2009 Aug;10(8):593-4. doi: 10.2459/JCM.0b013e32832e48f8. No abstract available.

PMID:
19564788
[PubMed - indexed for MEDLINE]
7.

New and emerging anticoagulant therapy for atrial fibrillation and acute coronary syndrome.

Davis EM, Packard KA, Knezevich JT, Campbell JA.

Pharmacotherapy. 2011 Oct;31(10):975-1016. doi: 10.1592/phco.31.10.975. Review.

PMID:
21950643
[PubMed - indexed for MEDLINE]
8.

Oral anticoagulation for atrial fibrillation after ST-elevation myocardial infarction: new evidence to guide clinical practice.

Kushner FG, Antman EM.

Circulation. 2005 Nov 22;112(21):3212-4. No abstract available.

PMID:
16301351
[PubMed - indexed for MEDLINE]
Free Article
9.

New oral anticoagulants: great promise for therapeutic advance but great knowledge gaps remain to be filled.

Innasimuthu AL, Kumar S, Akter S, Borer JS.

Cardiology. 2013;126(1):41-9. doi: 10.1159/000353484. Epub 2013 Jul 16. No abstract available.

PMID:
23860301
[PubMed - indexed for MEDLINE]
10.

Rivaroxaban, an oral direct factor Xa inhibitor.

Piccini JP, Patel MR, Mahaffey KW, Fox KA, Califf RM.

Expert Opin Investig Drugs. 2008 Jun;17(6):925-37. doi: 10.1517/13543784.17.6.925 . Review.

PMID:
18491993
[PubMed - indexed for MEDLINE]
11.

From monitoring to vigilance about patient adherence to new oral anticoagulants.

Vrijens B, Urquhart J.

Europace. 2014 Jan;16(1):149. doi: 10.1093/europace/eut243. Epub 2013 Sep 26. No abstract available.

PMID:
24072444
[PubMed - indexed for MEDLINE]
12.

Authors' response: from monitoring to vigilance about patient adherence to new oral anticoagulants.

Heidbuchel H; all authors of the EHRA Practical Guide:, Verhamme P, Alings M, Antz M, Hacke W, Oldgren J, Sinnaeve P, John Camm A, Kirchhof P.

Europace. 2014 Jan;16(1):149-50. doi: 10.1093/europace/eut280. Epub 2013 Sep 26. No abstract available.

PMID:
24072449
[PubMed - indexed for MEDLINE]
13.

Association of age, gender, and weight on maintenance dose of intravenous unfractionated heparin.

Verma S, Kato S, Blum R, Shapira I, Friedmann P, Varma M.

Am J Hematol. 2010 Aug;85(8):624-6. doi: 10.1002/ajh.21751. No abstract available.

PMID:
20552595
[PubMed - indexed for MEDLINE]
14.

Novel drugs for oral anticoagulation pharmacotherapy.

Capodanno D, Giacchi G, Tamburino C.

Expert Rev Cardiovasc Ther. 2012 Apr;10(4):473-88. doi: 10.1586/erc.12.18. Review.

PMID:
22458580
[PubMed - indexed for MEDLINE]
15.

Novel oral anticoagulants: the potential relegation of vitamin K antagonists in clinical practice.

Wrigley BJ, Lip GY, Shantsila E.

Int J Clin Pract. 2010 Jun;64(7):835-8. doi: 10.1111/j.1742-1241.2010.02351.x. No abstract available.

PMID:
20584215
[PubMed - indexed for MEDLINE]
16.

New anticoagulants and the future of cardiology.

Andreotti F, Pafundi T.

Rev Esp Cardiol. 2010 Nov;63(11):1223-9. English, Spanish. No abstract available.

PMID:
21070716
[PubMed - indexed for MEDLINE]
Free Article
17.

Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/ stenting.

Lip GY, Huber K, Andreotti F, Arnesen H, Airaksinen KJ, Cuisset T, Kirchhof P, Marín F; European Society of Cardiology Working Group on Thrombosis.

Thromb Haemost. 2010 Jan;103(1):13-28. doi: 10.1160/TH09-08-0580. Epub 2009 Sep 30. Review. Erratum in: Thromb Haemost. 2010 Sep;104(3):653. Dosage error in article text.

PMID:
20062939
[PubMed - indexed for MEDLINE]
18.

Bleeding risk assessment and management in atrial fibrillation patients.

Lip GY.

Eur Heart J. 2012 Jan;33(2):147-9. doi: 10.1093/eurheartj/ehr431. No abstract available.

PMID:
22246817
[PubMed - indexed for MEDLINE]
Free Article
19.

New-onset atrial fibrillation and acute coronary syndrome.

Lau DH, Alasady M, Brooks AG, Sanders P.

Expert Rev Cardiovasc Ther. 2010 Jul;8(7):941-8. doi: 10.1586/erc.10.61. Review.

PMID:
20602555
[PubMed - indexed for MEDLINE]
20.

Glycoprotein inhibitors in patients on chronic anticoagulation: safe enough or too much risk?

Marín F, Bonacasa B, Valdés M.

Thromb Haemost. 2010 Jan;103(1):11-2. doi: 10.1160/TH09-10-0694. Epub 2009 Dec 1. No abstract available.

PMID:
20062940
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk